| Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis B Kilic, Y Guler, FN Azman, E Bostanci, S Ugurlu Rheumatology 63 (4), 925-935, 2024 | 3 | 2024 |
| Comment on: Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis B Kilic, K Parlar, S Ugurlu Rheumatology 63 (2), e56-e57, 2024 | 1 | 2024 |
| Cancer incidence in Familial Mediterranean Fever: A retrospective analysis SN Baspinar, B Kilic, FN Azman, Y Guler, UB Gunay, MK Tanin, G Can, ... Seminars in Arthritis and Rheumatism 63, 152284, 2023 | 1 | 2023 |
| AB1406 ANAKINRA IN THE MANAGEMENT OF ADULT-ONSET STILL’S DISEASE: A SINGLE-CENTER EXPERIENCE B Kilic, K Parlar, A Ozturk, S Karup, K Karaahmetli, Y Guler, S Ugurlu Annals of the Rheumatic Diseases 83 (Suppl 1), 2056-2057, 2024 | | 2024 |
| POS1193 EFFICACY AND SAFETY OF BIOLOGICAL DRUGS IN THE TREATMENT OF PEDIATRIC AND ADULT PATIENTS WITH STILL’S DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF … B Kilic, A Ozturk, S Karup, E Hacioglu, S Ugurlu Annals of the Rheumatic Diseases 83 (Suppl 1), 1117-1118, 2024 | | 2024 |
| Efficacy and Safety of Biological Drugs in Still's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials B Kilic, A Ozturk, S Karup, E Hacioglu, S Ugurlu Rheumatology, keae295, 2024 | | 2024 |
| Anakinra in the Management of Adult-Onset Still’s Disease: A Single-Center Experience B Kilic, K Parlar, S Karup, A Ozturk, K Karaahmetli, S Ugurlu | | 2024 |
| Novel janus-kinase (JAK) inhibitors in myelofibrosis Y Ipek, B Kilic, UB Gunay, AE Eskazan Expert Opinion on Investigational Drugs 32 (10), 931-940, 2023 | | 2023 |
| Cancer Incidence in Familial Mediterranean Fever SN Baspinar, B Kilic, F Azman, MB Yuzbasioglu, Y Guler, MK Tanin, ... ARTHRITIS & RHEUMATOLOGY 75, 263-265, 2023 | | 2023 |
